The introduction of new oncological therapies, particularly immunotherapies, is revolutionizing cancer treatment in Mexico by extending patient survival and improving quality of life. While Mexico lags slightly behind the U.S. in adoption, the gap is narrowing, significantly improving outcomes for advanced cancers like lung cancer.